Webinar Date & Time
25 February 2026 from 04:00 PM to 05:30 PM (CET)
Webinar Overview
In this webinar, we will begin with an expert-led overview of the current MDR landscape, presented by the Medical Device Working Group.
The regulatory landscape for medical devices (MDs) and in vitro diagnostics (IVDs) devices in Europe has undergone significant changes with the implementation of the Medical Device Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR). These regulations were designed to enhance safety, transparency, and innovation by creating a more robust, transparent, predictable and sustainable system.
Two EU Regulations IVD Regulation 2017/746/EU (IVDR) and Medical Devices Regulation 2017/745/EU (MDR) were published in May 2017 governing the safety and performance of devices across their lifetime.
Under these EU Regulations medical devices or diagnostics in Europe must go through an evaluation process called a ‘conformity assessment’. This process ensures that products placed on the market are compliant with the regulatory rules and presents more benefits than risks. The level of oversight depends on the risk class of the product: the higher the risk, the stricter the checks.
Before a medical technology can be legally placed on the EU market, a manufacturer must comply with the requirements of all applicable EU legislation and affix a CE mark to their device.
Subsequently, we will explore the rapidly evolving landscape of Software as a Medical Device (SaMD), focusing on how the EU MDR and the upcoming AI Act are reshaping compliance, innovation, and commercialization strategies. Drawing from real-world experience with Healthentia – one of the first SaMD apps in Europe certified under MDR Class IIa – we will highlight both the opportunities created by regulatory clarity and the operational challenges that manufacturers face when integrating AI-driven functionalities. Key topics will include navigating dual compliance (MDR & AI Act), balancing safety with agility, and strategies for separating medical-grade and wellbeing features to enable faster scaling. Participants will gain practical insights into building future-proof SaMD solutions that are both regulatory-compliant and business-viable.
Presenter
Dr. Sofoklis Kyriazakos
Founder and CEO
Healthentia
Dr. Sofoklis Kyriazakos is the Founder and CEO of Healthentia, a Belgian digital health company behind Healthentia, one of the first EU MDR Class IIa-certified Software as Medical Device apps for chronic disease management and behavioural change coaching. With a background in engineering, entrepreneurship, and academic research, Sofoklis has spent over 20 years working at the intersection of healthcare technologies, AI, and patient empowerment. His work focuses on remotely supporting patients through smart, data-driven interventions while ensuring compliance with evolving European regulations. He is an active speaker, panel moderator, and contributor in the fields of digital therapeutics, remote monitoring, and AI in health.
Attendance Fee
€ 90,- for non-EUCROF members
€ 60,- for EUCROF members
Deadline for registration
24 February 2026 at 6 p.m.
How to register?
1) Go on the REGISTRATION PAGE and click on the orange button “GET TICKETS”
2) Check your order and click on the green “CHECKOUT” button
3) Fill in all the necessary information and validate your order
Confirmation
You will receive 2 confirmation emails:
A) One from Eventbrite with your invoice
B) One from “Eucrof” with all the necessary information to connect the D-Day!
Questions?
Should you have any questions about registration, invoices or connection, do not hesitate and contact us by email at webinar@eucrof.eu
By registering to the webinar, you give your authorisation to the webinar organizers to use your email address and personal information to communicate with you about this event and future initiatives. To stop receiving their communications, please contact the organizers directly at info@eucrof.eu.
